Lessons from preclinical and clinical studies with 1,2-diethyl-3-hydroxypyridin-4-one, CP94 and related compounds

Adv Exp Med Biol. 1994:356:361-70. doi: 10.1007/978-1-4615-2554-7_38.
No abstract available

Publication types

  • Comparative Study
  • Review

MeSH terms

  • Animals
  • Cell Line
  • Deferoxamine / therapeutic use
  • Guinea Pigs
  • Humans
  • Iron / metabolism*
  • Iron Chelating Agents / pharmacokinetics
  • Iron Chelating Agents / therapeutic use*
  • Iron Chelating Agents / toxicity*
  • Mice
  • Pyridones / pharmacokinetics
  • Pyridones / therapeutic use*
  • Pyridones / toxicity*
  • Rats
  • Structure-Activity Relationship
  • Tumor Cells, Cultured
  • beta-Thalassemia / blood
  • beta-Thalassemia / drug therapy

Substances

  • Iron Chelating Agents
  • Pyridones
  • 1,2-diethyl-3-hydroxypyridin-4-one
  • Iron
  • Deferoxamine